Eli Lilly rolls out direct patient access to weight loss star Zepbound—at a deep discount

[cafead]

via Eli Lilly has come up with a new way of supplying its popular weight-loss drug Zepbound that the company hopes could expand access while addressing other issues such as high prices and off-label cosmetic usage.

article source